Revenue
2019
2020
2021
2022
2023
2024
2025
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
Price—Loading quote
Net income
2019
2020
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 · Dec 31 | 2020 · Nov 19 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $185.7M | $259.2M | $288.9M | $883.0M | $799.2M | $284.1M | — | $143.1M |
| Gross profit | $34.0M | $108.3M | $140.2M | — | — | — | — | — |
| Research & development | $17.4M | $19.2M | $17.3M | $18.4M | $15.2M | $9.3M | — | $3.6M |
| Operating income | −$215.3M | −$235.6M | −$31.6M | $574.2M | $554.6M | $119.9M | — | $24.0M |
| EBITDAderived | −$163.8M | −$187.2M | $8.6M | $606.1M | $579.4M | $145.8M | — | $48.1M |
| Net income | −$130.8M | −$144.8M | −$119.0M | $220.2M | $182.0M | $89.0M | $88.2M | −$4.5M |
| Basic EPSper diluted share | -$0.90 | -$1.05 | -$0.90 | $1.67 | $1.59 | $7.43 | — | -$0.03 |
| Diluted EPSper diluted share | -$0.90 | -$1.05 | -$0.90 | $1.67 | $1.56 | $2.36 | — | -$0.03 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026Form 4 · 10b5-1 | ORESHACK KURTGeneral Counsel | SellClass A Common Stock | 25.0K | $5.10 | $127.5K | 335.8K |
| Jun 9, 2026Form 4 · 10b5-1 | ORESHACK KURTGeneral Counsel | SellClass A Common Stock | 25.0K | $5.06 | $126.5K | 360.8K |
| Dec 8, 2025Form 4 | LUCIER GREGORY TDirector | BuyClass A Common Stock | 48.5K | $3.67 | $178.1K | 155.1K |
| Dec 5, 2025Form 4 | LUCIER GREGORY TDirector | BuyClass A Common Stock | 51.5K | $3.70 | $190.4K | 106.6K |
| Nov 13, 2025Form 4 | Brust BerndChief Executive Officer | BuyClass A Common Stock · indirect | 216.2K | $3.25 | $702.7K | 466.8K |